Literature DB >> 8060315

Identification of a vitamin D receptor homodimer-type response element in the rat calcitriol 24-hydroxylase gene promoter.

J P Kahlen1, C Carlberg.   

Abstract

Calcitriol (1,25-dihydroxyvitamin D3, VD) controls multiple aspects of homeostasis, cell growth and differentiation by the action of its nuclear receptor (VDR), which binds to, and activates transcription from, response elements in the promoter region of its target genes. One of these target genes is calcitriol 24-hydroxylase, an enzyme that initiates the degradation of 25-dihydroxyvitamin D3 (calcidiol) and calcitriol. We screened the promoter of rat calcitriol 24-hydroxylase for potential VDR binding sites and identified a functional VD response element, between positions -250 and -233. This response element consists of two directly repeated hexameric core binding motifs spaced by six nucleotides and confers VD-dependent transactivation mediated by VDR homodimers or alternatively by heterodimers formed by VDR and retinoic acid receptor (RAR). Its structure and function are very similar to those of the homodimer-type response element of the human osteocalcin promoter.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8060315     DOI: 10.1006/bbrc.1994.2081

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  7 in total

1.  The vitamin D(3) receptor in the context of the nuclear receptor superfamily : The central role of the retinoid X receptor.

Authors:  C Carlberg
Journal:  Endocrine       Date:  1996-04       Impact factor: 3.633

2.  Natural vitamin D3 response elements formed by inverted palindromes: polarity-directed ligand sensitivity of vitamin D3 receptor-retinoid X receptor heterodimer-mediated transactivation.

Authors:  M Schräder; S Nayeri; J P Kahlen; K M Müller; C Carlberg
Journal:  Mol Cell Biol       Date:  1995-03       Impact factor: 4.272

Review 3.  Perspectives of differentiation therapies of acute myeloid leukemia: the search for the molecular basis of patients' variable responses to 1,25-dihydroxyvitamin d and vitamin d analogs.

Authors:  Aleksandra Marchwicka; Małgorzata Cebrat; Preetha Sampath; Lukasz Snieżewski; Ewa Marcinkowska
Journal:  Front Oncol       Date:  2014-05-27       Impact factor: 6.244

4.  Diverse Regulation of Vitamin D Receptor Gene Expression by 1,25-Dihydroxyvitamin D and ATRA in Murine and Human Blood Cells at Early Stages of Their Differentiation.

Authors:  Sylwia Janik; Urszula Nowak; Agnieszka Łaszkiewicz; Anastasiia Satyr; Michał Majkowski; Aleksandra Marchwicka; Łukasz Śnieżewski; Klaudia Berkowska; Marian Gabryś; Małgorzata Cebrat; Ewa Marcinkowska
Journal:  Int J Mol Sci       Date:  2017-06-21       Impact factor: 5.923

5.  Selective use of multiple vitamin D response elements underlies the 1 alpha,25-dihydroxyvitamin D3-mediated negative regulation of the human CYP27B1 gene.

Authors:  Mikko M Turunen; Thomas W Dunlop; Carsten Carlberg; Sami Väisänen
Journal:  Nucleic Acids Res       Date:  2007-04-10       Impact factor: 16.971

6.  Regulation of Expression of CEBP Genes by Variably Expressed Vitamin D Receptor and Retinoic Acid Receptor α in Human Acute Myeloid Leukemia Cell Lines.

Authors:  Aleksandra Marchwicka; Ewa Marcinkowska
Journal:  Int J Mol Sci       Date:  2018-06-29       Impact factor: 5.923

7.  A novel vitamin D gene therapy for acute myeloid leukemia.

Authors:  Yi Xu; Kimberly Payne; Linh Hoang Gia Pham; Park Eunwoo; Jeffrey Xiao; David Chi; Justin Lyu; Rosalia Campion; Samiksha Wasnik; Il Seok Jeong; Xiaolei Tang; David Jeston Baylink; Chien Shing Chen; Mark Reeves; Mojtaba Akhtari; Saied Mirshahidi; Guido Marcucci; Huynh Cao
Journal:  Transl Oncol       Date:  2020-09-18       Impact factor: 4.243

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.